Skip to main content
Top
Published in: BMC Public Health 1/2012

Open Access 01-12-2012 | Research article

Prevalence of metabolic syndrome (MetS) in Chinese subjects gradually increased with impaired glucose homeostasis: a multicenter, clinical based, cross-sectional study

Authors: Yufei Xiang, Gan Huang, Weidong Zhou, Zhihong Che, Pengcheng Zhou, Zhiguang Zhou

Published in: BMC Public Health | Issue 1/2012

Login to get access

Abstract

Background

Metabolic Syndrome (MetS) is a high risk factor for Cardiovascular Diseases (CVD). We estimated to investigate how MetS prevalence by glucose homeostasis varies across different age and gender groups.

Methods

We studied 9257 Chinese subjects over the age of 15 years in two cross-sectional surveys in 2006. With oral glucose tolerance test (OGTT) test, 2341 subjects were normal glucose tolerance (NGT), and 5448 were diagnosed as having type 2 diabetes (T2D). All other 1468 subjects were considered to be impaired fasting glucose (IFG) or impaired glucose tolerance (IGT) subjects. Diabetes was diagnosis by WHO99 criteria. We used modified NCEP-III criteria for the diagnosis of MetS.

Results

The prevalences of MetS in the male NGT, IFG/IGT and T2D groups were 25.9% (404/1559), 65.6% (769/1172), and 73.5% (2483/3376), respectively. The prevalences of MetS in the female NGT, IFG/IGT and T2D groups were 13.4% (105/782), 51.0% (151/296), and 75.4% (1563/2072), respectively. The prevalence of MetS in the male IFG/IGT group gradually decreased from 73.26% to 41.08% in subjects over the age of 30 years. The prevalence of MetS in the female IFG/IGT group gradually increased from 30% to 75% with aging.

Conclusions

The prevalence of MetS in subjects with different glucose tolerances in China was high and gradually increased with impaired glucose homeostasis both in males and females.
Literature
1.
go back to reference Steinberger J, Daniels SR, Eckel RH, et al: Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2009, 119: 628-647. 10.1161/CIRCULATIONAHA.108.191394.CrossRefPubMed Steinberger J, Daniels SR, Eckel RH, et al: Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2009, 119: 628-647. 10.1161/CIRCULATIONAHA.108.191394.CrossRefPubMed
2.
go back to reference Grundy SM, Cleeman JI, Daniels SR, et al: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112: 2735-2752. 10.1161/CIRCULATIONAHA.105.169404.CrossRefPubMed Grundy SM, Cleeman JI, Daniels SR, et al: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112: 2735-2752. 10.1161/CIRCULATIONAHA.105.169404.CrossRefPubMed
3.
go back to reference Hunt KJ, Resendez RG, Williams K, et al: National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation. 2004, 110: 1251-1257. 10.1161/01.CIR.0000140762.04598.F9.CrossRefPubMed Hunt KJ, Resendez RG, Williams K, et al: National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation. 2004, 110: 1251-1257. 10.1161/01.CIR.0000140762.04598.F9.CrossRefPubMed
4.
go back to reference Chan JC, Malik V, Jia W, et al: Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009, 301: 2129-2140. 10.1001/jama.2009.726.CrossRefPubMed Chan JC, Malik V, Jia W, et al: Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009, 301: 2129-2140. 10.1001/jama.2009.726.CrossRefPubMed
5.
go back to reference Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.CrossRef Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.CrossRef
6.
go back to reference Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, et al: Prevalence of the metabolic syndrome among Omani adults. Diabetes Care. 2003, 26: 1781-1785. 10.2337/diacare.26.6.1781.CrossRefPubMed Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, et al: Prevalence of the metabolic syndrome among Omani adults. Diabetes Care. 2003, 26: 1781-1785. 10.2337/diacare.26.6.1781.CrossRefPubMed
7.
go back to reference Jaber LA, Brown MB, Hammad A, et al: The prevalence of the metabolic syndrome among arab americans. Diabetes Care. 2004, 27: 234-238. 10.2337/diacare.27.1.234.CrossRefPubMed Jaber LA, Brown MB, Hammad A, et al: The prevalence of the metabolic syndrome among arab americans. Diabetes Care. 2004, 27: 234-238. 10.2337/diacare.27.1.234.CrossRefPubMed
8.
go back to reference Ilanne-Parikka P, Eriksson JG, Lindstrom J, et al: Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort. Diabetes Care. 2004, 27: 2135-2140. 10.2337/diacare.27.9.2135.CrossRefPubMed Ilanne-Parikka P, Eriksson JG, Lindstrom J, et al: Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort. Diabetes Care. 2004, 27: 2135-2140. 10.2337/diacare.27.9.2135.CrossRefPubMed
9.
go back to reference Ford ES: Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005, 28: 2745-2749. 10.2337/diacare.28.11.2745.CrossRefPubMed Ford ES: Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005, 28: 2745-2749. 10.2337/diacare.28.11.2745.CrossRefPubMed
10.
go back to reference Ford ES, Ajani UA, Mokdad AH: The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care. 2005, 28: 878-881. 10.2337/diacare.28.4.878.CrossRefPubMed Ford ES, Ajani UA, Mokdad AH: The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care. 2005, 28: 878-881. 10.2337/diacare.28.4.878.CrossRefPubMed
11.
go back to reference Misra A, Khurana L: Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab. 2008, 93: S9-S30. 10.1210/jc.2008-1595.CrossRefPubMed Misra A, Khurana L: Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab. 2008, 93: S9-S30. 10.1210/jc.2008-1595.CrossRefPubMed
12.
go back to reference Liu J, Grundy SM, Wang W, et al: Ethnic-specific criteria for the metabolic syndrome: evidence from China. Diabetes Care. 2006, 29: 1414-1416. 10.2337/dc06-0481.CrossRefPubMed Liu J, Grundy SM, Wang W, et al: Ethnic-specific criteria for the metabolic syndrome: evidence from China. Diabetes Care. 2006, 29: 1414-1416. 10.2337/dc06-0481.CrossRefPubMed
13.
go back to reference Gu D, Reynolds K, Wu X, et al: Prevalence of the metabolic syndrome and overweight among adults in China. Lancet. 2005, 365: 1398-1405. 10.1016/S0140-6736(05)66375-1.CrossRefPubMed Gu D, Reynolds K, Wu X, et al: Prevalence of the metabolic syndrome and overweight among adults in China. Lancet. 2005, 365: 1398-1405. 10.1016/S0140-6736(05)66375-1.CrossRefPubMed
14.
go back to reference Wang JJ, Hu G, Lappalainen J, et al: Changes in features of the metabolic syndrome and incident impaired glucose regulation or type 2 diabetes in a chinese population. Diabetes Care. 2005, 28: 448-450. 10.2337/diacare.28.2.448.CrossRefPubMed Wang JJ, Hu G, Lappalainen J, et al: Changes in features of the metabolic syndrome and incident impaired glucose regulation or type 2 diabetes in a chinese population. Diabetes Care. 2005, 28: 448-450. 10.2337/diacare.28.2.448.CrossRefPubMed
15.
go back to reference Yang W, Lu J, Weng J, et al: Prevalence of diabetes among men and women in China. N Engl J Med. 2010, 362: 1090-1101. 10.1056/NEJMoa0908292.CrossRefPubMed Yang W, Lu J, Weng J, et al: Prevalence of diabetes among men and women in China. N Engl J Med. 2010, 362: 1090-1101. 10.1056/NEJMoa0908292.CrossRefPubMed
16.
go back to reference Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000, 894: 1-253. i-xii Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000, 894: 1-253. i-xii
17.
go back to reference Chalmers J, MacMahon S, Mancia G, et al: 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens. 1999, 21: 1009-1060.CrossRefPubMed Chalmers J, MacMahon S, Mancia G, et al: 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens. 1999, 21: 1009-1060.CrossRefPubMed
18.
go back to reference Hanefeld M, Karasik A, Koehler C, et al: Metabolic syndrome and its single traits as risk factors for diabetes in people with impaired glucose tolerance: the STOP-NIDDM trial. Diab Vasc Dis Res. 2009, 6: 32-37. 10.3132/dvdr.2009.006.CrossRefPubMed Hanefeld M, Karasik A, Koehler C, et al: Metabolic syndrome and its single traits as risk factors for diabetes in people with impaired glucose tolerance: the STOP-NIDDM trial. Diab Vasc Dis Res. 2009, 6: 32-37. 10.3132/dvdr.2009.006.CrossRefPubMed
19.
go back to reference Isomaa B, Almgren P, Tuomi T, et al: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001, 24: 683-689. 10.2337/diacare.24.4.683.CrossRefPubMed Isomaa B, Almgren P, Tuomi T, et al: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001, 24: 683-689. 10.2337/diacare.24.4.683.CrossRefPubMed
20.
go back to reference Hanefeld M, Koehler C, Gallo S, et al: Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study. Cardiovasc Diabetol. 2007, 6: 13-10.1186/1475-2840-6-13.CrossRefPubMedPubMedCentral Hanefeld M, Koehler C, Gallo S, et al: Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study. Cardiovasc Diabetol. 2007, 6: 13-10.1186/1475-2840-6-13.CrossRefPubMedPubMedCentral
21.
go back to reference Guzder RN, Gatling W, Mullee MA, et al: Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes. Diabetologia. 2006, 49: 49-55. 10.1007/s00125-005-0063-9.CrossRefPubMed Guzder RN, Gatling W, Mullee MA, et al: Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes. Diabetologia. 2006, 49: 49-55. 10.1007/s00125-005-0063-9.CrossRefPubMed
22.
go back to reference Lorenzo C, Williams K, Hunt KJ, et al: Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the San Antonio Heart Study. Diabetes Care. 2006, 29: 625-630. 10.2337/diacare.29.03.06.dc05-1755.CrossRefPubMed Lorenzo C, Williams K, Hunt KJ, et al: Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the San Antonio Heart Study. Diabetes Care. 2006, 29: 625-630. 10.2337/diacare.29.03.06.dc05-1755.CrossRefPubMed
23.
go back to reference Hawa MI, Thivolet C, Mauricio D, et al: Metabolic syndrome and autoimmune diabetes: action LADA 3. Diabetes Care. 2009, 32: 160-164. 10.2337/dc08-1419.CrossRefPubMedPubMedCentral Hawa MI, Thivolet C, Mauricio D, et al: Metabolic syndrome and autoimmune diabetes: action LADA 3. Diabetes Care. 2009, 32: 160-164. 10.2337/dc08-1419.CrossRefPubMedPubMedCentral
24.
go back to reference Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002, 287: 356-359. 10.1001/jama.287.3.356.CrossRefPubMed Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002, 287: 356-359. 10.1001/jama.287.3.356.CrossRefPubMed
25.
go back to reference Tan CE, Ma S, Wai D, et al: Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?. Diabetes Care. 2004, 27: 1182-1186. 10.2337/diacare.27.5.1182.CrossRefPubMed Tan CE, Ma S, Wai D, et al: Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?. Diabetes Care. 2004, 27: 1182-1186. 10.2337/diacare.27.5.1182.CrossRefPubMed
26.
go back to reference Muller M, Grobbee DE, den Tonkelaar I, et al: Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab. 2005, 90: 2618-2623. 10.1210/jc.2004-1158.CrossRefPubMed Muller M, Grobbee DE, den Tonkelaar I, et al: Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab. 2005, 90: 2618-2623. 10.1210/jc.2004-1158.CrossRefPubMed
27.
go back to reference Laaksonen DE, Niskanen L, Punnonen K, et al: Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol. 2003, 149: 601-608. 10.1530/eje.0.1490601.CrossRefPubMed Laaksonen DE, Niskanen L, Punnonen K, et al: Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol. 2003, 149: 601-608. 10.1530/eje.0.1490601.CrossRefPubMed
Metadata
Title
Prevalence of metabolic syndrome (MetS) in Chinese subjects gradually increased with impaired glucose homeostasis: a multicenter, clinical based, cross-sectional study
Authors
Yufei Xiang
Gan Huang
Weidong Zhou
Zhihong Che
Pengcheng Zhou
Zhiguang Zhou
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2012
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-12-675

Other articles of this Issue 1/2012

BMC Public Health 1/2012 Go to the issue